{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:28:52Z","timestamp":1793647732155,"version":"4.5.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Recent research showed that oral microbiomes (OMs), as the main source of lung microbiomes, were associated with lung cancer (LC), but the causal relationship and mechanisms remain unclear. This study aimed to explore the immune mechanisms of LC through the \u201cOM - inflammatory proteins - LC\u201d axis. Instrumental variables covering 43 oral microbial taxa, 91 circulating inflammatory proteins, and LC subtypes were obtained from large-scale genome-wide association study summary data of European origin. We employed Mendelian randomization (MR) analysis to validate causal links between the OM and LC and to assess the mediation effects of inflammatory proteins. The primary statistical method was the inverse variance weighted method, supplemented by leave-one-out analysis, MR-Egger regression, and Cochran\u2019s Q test to assess heterogeneity and pleiotropy. Finally, we calculated the effect size of inflammatory proteins as mediators. The results suggested that 9 oral microbial taxa and 20 inflammatory proteins were significantly associated with LC and its subtypes. Key findings included: Genus\n                      <jats:italic toggle=\"yes\">Rothia<\/jats:italic>\n                      increased the risk of squamous cell carcinoma. At the species level,\n                      <jats:italic toggle=\"yes\">Haemophilus parainfluenzae<\/jats:italic>\n                      protected against lung adenocarcinoma, whereas\n                      <jats:italic toggle=\"yes\">Megasphaera micronuciformis<\/jats:italic>\n                      prevented small cell LC. Among the inflammatory proteins, the protein S100-A12 elevated adenocarcinoma risk, and STAM binding protein increased the risk of squamous cell carcinoma. Protective proteins included artemin (squamous cell carcinoma), cystatin D (adenocarcinoma), and interleukin 18 (both subtypes mentioned above).\n                      <jats:italic toggle=\"yes\">M. micronuciformis<\/jats:italic>\n                      and overall LC had a causal relationship in which cystatin D played a mediating role. This study reveals a potential causal link between the OM, circulating inflammatory proteins, and LC. The protective effect of\n                      <jats:italic toggle=\"yes\">M. micronuciformis<\/jats:italic>\n                      was mediated by cystatin D, highlighting a novel immune pathway. These findings provide biomarkers for early detection of LC and therapeutic targets for LC intervention.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051142","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:00:53Z","timestamp":1792173653000},"page":"e51142","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between oral microbiome, circulating inflammatory proteins and lung cancer"],"prefix":"10.1097","volume":"105","author":[{"given":"Songhe","family":"Ping","sequence":"first","affiliation":[{"name":"School of Medicine, Shaoxing University, Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shaoxing People\u2019s Hospital (The First Affiliated Hospital of Shaoxing University), Shaoxing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shaoxing People\u2019s Hospital (The First Affiliated Hospital of Shaoxing University), Shaoxing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelong","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Shaoxing People\u2019s Hospital (The First Affiliated Hospital of Shaoxing University), Shaoxing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shaoxing People\u2019s Hospital (The First Affiliated Hospital of Shaoxing University), Shaoxing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renqi","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Medicine, Shaoxing University, Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Shan","sequence":"additional","affiliation":[{"name":"School of Medicine, Shaoxing University, Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ye","sequence":"additional","affiliation":[{"name":"School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3922-6457","authenticated-orcid":false,"given":"Meng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shaoxing People\u2019s Hospital (The First Affiliated Hospital of Shaoxing University), Shaoxing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261102","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20261102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer.","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20261102","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer.","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"key":"R4-20261102","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jtho.2023.11.016","article-title":"Allelic context of EGFR C797X-mutant lung cancer defines four subtypes with heterogeneous genomic landscape and distinct clinical outcomes.","volume":"19","author":"Lu","year":"2024","journal-title":"J Thorac Oncol"},{"key":"R5-20261102","doi-asserted-by":"crossref","first-page":"1973241","DOI":"10.1155\/2020\/1973241","article-title":"EGFR polymorphism and survival of NSCLC patients treated with TKIs: a systematic review and meta-analysis.","volume":"2020","author":"Jurisic","year":"2020","journal-title":"J Oncol"},{"key":"R6-20261102","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11033-025-11242-3","article-title":"The - 216G\/T polymorphism in the EGFR gene: a review focusing on non-small lung cancer.","volume":"53","author":"Obradovic","year":"2025","journal-title":"Mol Biol Rep"},{"key":"R7-20261102","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11033-025-10447-w","article-title":"Investigating the frequencies of EGFR mutations and EGFR single nucleotide polymorphisms genotypes and their predictive role in NSCLC patients in Republic of Serbia.","volume":"52","author":"Obradovi\u0107","year":"2025","journal-title":"Mol Biol Rep"},{"key":"R8-20261102","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","article-title":"Challenges of small cell lung cancer heterogeneity and phenotypic plasticity.","volume":"25","author":"Simpson","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"R9-20261102","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cncr.35281","article-title":"The changing landscape of small cell lung cancer.","volume":"130","author":"Cittolin-Santos","year":"2024","journal-title":"Cancer"},{"key":"R10-20261102","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s12032-013-0823-1","article-title":"The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.","volume":"31","author":"Petrovi\u0107","year":"2014","journal-title":"Med Oncol"},{"key":"R11-20261102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41579-023-00963-6","article-title":"The oral microbiome: diversity, biogeography and human health.","volume":"22","author":"Baker","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"R12-20261102","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/thoraxjnl-2020-215542","article-title":"Variation in oral microbiome is associated with future risk of lung cancer among never-smokers.","volume":"76","author":"Hosgood","year":"2021","journal-title":"Thorax"},{"key":"R13-20261102","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/jnci\/djac149","article-title":"The oral microbiome and lung cancer risk: an analysis of 3 prospective cohort studies.","volume":"114","author":"Vogtmann","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"R14-20261102","doi-asserted-by":"crossref","first-page":"1482084","DOI":"10.3389\/fimmu.2024.1482084","article-title":"Streptococcus intermedius promotes synchronous multiple primary lung cancer progression through apoptosis regulation.","volume":"15","author":"Deng","year":"2024","journal-title":"Front Immunol"},{"key":"R15-20261102","doi-asserted-by":"crossref","first-page":"102544","DOI":"10.1016\/j.tranon.2025.102544","article-title":"Editorial: significance cytokines in immuno oncology and immunotherapy.","volume":"62","author":"Jurisic","year":"2025","journal-title":"Transl Oncol"},{"key":"R16-20261102","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","article-title":"Myc cooperates with Ras by programming inflammation and immune suppression.","volume":"171","author":"Kortlever","year":"2017","journal-title":"Cell"},{"key":"R17-20261102","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1158\/0008-5472.CAN-20-3454","article-title":"Prospective identification of elevated circulating CDCP1 in patients years before onset of lung cancer.","volume":"81","author":"Dagnino","year":"2021","journal-title":"Cancer Res"},{"key":"R18-20261102","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-025-02276-z","article-title":"IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer.","volume":"24","author":"Ranjan","year":"2025","journal-title":"Mol Cancer"},{"key":"R19-20261102","doi-asserted-by":"crossref","first-page":"e191070","DOI":"10.1172\/JCI191070","article-title":"Lung adenocarcinoma-derived IFN-\u03b3 promotes growth by modulating CD8+ T cell production of CCR5 chemokines.","volume":"135","author":"Kratzmeier","year":"2025","journal-title":"J Clin Invest"},{"key":"R20-20261102","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.immuni.2023.01.010","article-title":"Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer.","volume":"56","author":"Zagorulya","year":"2023","journal-title":"Immunity"},{"key":"R21-20261102","article-title":"Proteogenomics in human populations [published online ahead of print August 20, 2026].","author":"Zhai","journal-title":"Nat Rev Genet"},{"key":"R22-20261102","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"R23-20261102","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jbmr\/zjae136","article-title":"Causal inference in health and disease: a review of the principles and applications of Mendelian randomization.","volume":"39","author":"Lovegrove","year":"2024","journal-title":"J Bone Miner Res"},{"key":"R24-20261102","doi-asserted-by":"crossref","first-page":"1425802","DOI":"10.3389\/fnut.2024.1425802","article-title":"Gut microbiota influence on lung cancer risk through blood metabolite mediation: from a comprehensive Mendelian randomization analysis and genetic analysis.","volume":"11","author":"Du","year":"2024","journal-title":"Front Nutr"},{"key":"R25-20261102","doi-asserted-by":"crossref","first-page":"1448629","DOI":"10.3389\/fmicb.2024.1448629","article-title":"Unveiling genetic links between gut microbiota and asthma: a Mendelian randomization.","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Microbiol"},{"key":"R26-20261102","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1038\/s41467-025-58248-w","article-title":"A genome-wide cross-trait analysis characterizes the shared genetic architecture between lung and gastrointestinal diseases.","volume":"16","author":"You","year":"2025","journal-title":"Nat Commun"},{"key":"R27-20261102","doi-asserted-by":"crossref","first-page":"14738","DOI":"10.1038\/s41598-024-65538-8","article-title":"Genome-wide association study identifies host genetic variants influencing oral microbiota diversity and metabolic health.","volume":"14","author":"Stankevic","year":"2024","journal-title":"Sci Rep"},{"key":"R28-20261102","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R29-20261102","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ng.3892","article-title":"Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.","volume":"49","author":"McKay","year":"2017","journal-title":"Nat Genet"},{"key":"R30-20261102","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12967-024-05255-y","article-title":"Omeprazole and risk of osteoarthritis: insights from a Mendelian randomization study in the UK Biobank.","volume":"22","author":"Cao","year":"2024","journal-title":"J Transl Med"},{"key":"R31-20261102","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41598-023-50351-6","article-title":"Dark chocolate intake and cardiovascular diseases: a Mendelian randomization study.","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"R32-20261102","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2337\/dc22-2373","article-title":"Bidirectional Mendelian randomization and multiphenotype GWAS show causality and shared pathophysiology between depression and type 2 diabetes.","volume":"46","author":"Maina","year":"2023","journal-title":"Diabetes Care"},{"key":"R33-20261102","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12933-024-02210-5","article-title":"Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study.","volume":"23","author":"Guo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R34-20261102","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/dom.16045","article-title":"Association and mediation pathways of maternal hyperglycaemia and liability to gestational diabetes with neonatal outcomes: a two-sample Mendelian randomization study.","volume":"27","author":"He","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"R35-20261102","doi-asserted-by":"crossref","first-page":"104877","DOI":"10.1016\/j.meegid.2021.104877","article-title":"Characterization of the Rothia spp. and their role in human clinical infections.","volume":"93","author":"Fatahi-Bafghi","year":"2021","journal-title":"Infect Genet Evol"},{"key":"R36-20261102","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1097\/JS9.0000000000002152","article-title":"Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study.","volume":"111","author":"Ma","year":"2025","journal-title":"Int J Surg"},{"key":"R37-20261102","doi-asserted-by":"crossref","first-page":"892613","DOI":"10.3389\/fbioe.2022.892613","article-title":"The microbiome of lower respiratory tract and tumor tissue in lung cancer manifested as radiological ground-glass opacity.","volume":"10","author":"Wu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"R38-20261102","doi-asserted-by":"crossref","first-page":"e0128424","DOI":"10.1128\/spectrum.01284-24","article-title":"16S rRNA sequencing reveals relationships among enrichment of oral microbiota in the lower respiratory tract and pulmonary nodules malignant progression.","volume":"13","author":"Guo","year":"2025","journal-title":"Microbiol Spectr"},{"key":"R39-20261102","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/microorganisms11030546","article-title":"Association studies on gut and lung microbiomes in patients with lung adenocarcinoma.","volume":"11","author":"Guo","year":"2023","journal-title":"Microorganisms"},{"key":"R40-20261102","first-page":"5466853","article-title":"Intratumoral microbiota impacts the first-line treatment efficacy and survival in non-small cell lung cancer patients free of lung infection.","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Healthc Eng"},{"issue":"Pt 2","key":"R41-20261102","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1099\/ijs.0.02378-0","article-title":"Phylogenetic analysis of some Sporomusa sub-branch members isolated from human clinical specimens: description of Megasphaera micronuciformis sp. nov.","volume":"53","author":"Marchandin","year":"2003","journal-title":"Int J Syst Evol Microbiol"},{"key":"R42-20261102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","article-title":"Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions.","volume":"102","author":"Lee","year":"2016","journal-title":"Lung Cancer"},{"key":"R43-20261102","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcancer.2026.06.006","article-title":"Role of oral microbiome in cancer immunotherapy.","volume":"125","author":"Khalil","year":"2026","journal-title":"Semin Cancer Biol"},{"key":"R44-20261102","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/pathogens14121233","article-title":"Oral microbiota and carcinogenesis: exploring the systemic impact of oral pathogens.","volume":"14","author":"Nikoli\u0107","year":"2025","journal-title":"Pathogens"},{"key":"R45-20261102","doi-asserted-by":"crossref","first-page":"104501","DOI":"10.1016\/j.bioorg.2020.104501","article-title":"Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1\/C2 inhibitors for the treatment of lung cancer.","volume":"106","author":"Chaube","year":"2021","journal-title":"Bioorg Chem"},{"key":"R46-20261102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11418-020-01435-4","article-title":"Sauchinone: a prospective therapeutic agent-mediated EIF4EBP1 down-regulation suppresses proliferation, invasion and migration of lung adenocarcinoma cells.","volume":"74","author":"Li","year":"2020","journal-title":"J Nat Med"},{"key":"R47-20261102","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s10495-019-01559-3","article-title":"Inhibition of SIRT1\/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells.","volume":"24","author":"Mu","year":"2019","journal-title":"Apoptosis"},{"key":"R48-20261102","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-015-1860-2","article-title":"Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.","volume":"467","author":"Roh","year":"2015","journal-title":"Virchows Arch"},{"key":"R49-20261102","doi-asserted-by":"crossref","first-page":"23156","DOI":"10.1016\/S0021-9258(17)31633-2","article-title":"Structural and functional characterization of two allelic variants of human cystatin D sharing a characteristic inhibition spectrum against mammalian cysteine proteinases.","volume":"269","author":"Balb\u00edn","year":"1994","journal-title":"J Biol Chem"},{"key":"R50-20261102","doi-asserted-by":"crossref","first-page":"18221","DOI":"10.1074\/jbc.M411914200","article-title":"Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile.","volume":"280","author":"Alvarez-Fernandez","year":"2005","journal-title":"J Biol Chem"},{"key":"R51-20261102","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.1074\/jbc.M115.660175","article-title":"Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.","volume":"290","author":"Ferrer-Mayorga","year":"2015","journal-title":"J Biol Chem"},{"key":"R52-20261102","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1172\/JCI37205","article-title":"Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells.","volume":"119","author":"Alvarez-D\u00edaz","year":"2009","journal-title":"J Clin Invest"},{"key":"R53-20261102","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jsbmb.2010.02.031","article-title":"The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling.","volume":"121","author":"Ord\u00f3\u00f1ez-Mor\u00e1n","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R54-20261102","doi-asserted-by":"crossref","first-page":"15842","DOI":"10.18632\/oncotarget.4683","article-title":"p53 directly activates cystatin D\/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3.","volume":"6","author":"H\u00fcnten","year":"2015","journal-title":"Oncotarget"},{"key":"R55-20261102","doi-asserted-by":"crossref","first-page":"e70112","DOI":"10.1111\/crj.70112","article-title":"Causal associations between cystatin and lung cancer: a two-sample Mendelian randomization study.","volume":"19","author":"Zhang","year":"2025","journal-title":"Clin Respir J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:00:59Z","timestamp":1793646059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051142"}},"subtitle":["A Mendelian randomization study"],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":55,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051142","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2025-10-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}